"Capsules" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Hard or soft soluble containers used for the oral administration of medicine.
Below are MeSH descriptors whose meaning is more general than "Capsules".
Below are MeSH descriptors whose meaning is more specific than "Capsules".
This graph shows the total number of publications written about "Capsules" by people in this website by year, and whether "Capsules" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Capsules" by people in Profiles.
Agreement of telemetric temperature capsules ingested 48 hours apart. J Therm Biol. 2022 Aug; 108:103271.
Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy Volunteers. Clin Pharmacol Drug Dev. 2021 10; 10(10):1198-1208.
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood. 2020 08 06; 136(6):674-683.
Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol. Am J Transplant. 2018 03; 18(3):590-603.
Open-Capsule Budesonide for Refractory Celiac Disease. Am J Gastroenterol. 2017 Jun; 112(6):959-967.
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621). Pediatr Blood Cancer. 2014 Jun; 61(6):990-6.
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer. Eur J Cancer. 2013 Sep; 49(14):2972-8.
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group. Clin Cancer Res. 2011 Nov 01; 17(21):6858-66.
The manufacture of low-dose oral solid dosage form to support early clinical studies using an automated micro-filing system. AAPS PharmSciTech. 2011 Mar; 12(1):88-95.
Biocompatibility investigation of polyethylene glycol and alginate-poly-L-lysine for islet encapsulation. ASAIO J. 2010 May-Jun; 56(3):241-5.